You are here: Home The ZBSA News Events SystemsBiology. Challenges.Society. Program
Document Actions

Program

 

International Symposium on Systems Biology in Freiburg, June 17-19 2009

 

 

 

 

 

 

 

 

 

                Program                                         Registration & Accomodation                                 Contact         

 

Location:  Auditorium of Biology II, Schänzlestr. 1, Freiburg

 

Wednesday, 17.6.2009 · ZBSA Official Opening Ceremony (Free registration online)

18:00

18:30

 

Addmittance

Welcome by Prof. Dr. Hans-Jochen Schiewer, Rector

Panel discussion „Systems Biology.Challenges.Society“ with: Prof. Ralf Baumeister, director ZBSA; Prof. Dr. Giovanni Maio, Institute of Bioethics at the University of Freiburg; Dr. Ralf Kindervater, director Bio-Pro Baden-Württemberg GmbH; Prof. Dr. Klaus Mainzer, scientific director oft the Carl von Linde-Akademie, TU München; Chair: Dr. Norbert Lossau, senior-science editor, „Die Welt“

Followed by Banquet in and around the new ZBSA building

trennlinie.png

 

 Thursday, 18.06.2009 · (Fee requiered for registration online)

09:00-09:45

10:00-10:45

Prof. Béla Novák

Dr. Jonathan Swinton

Main presentations

University of Oxford

AstraZeneca, United Kingdom

trennlinie.png

11:30-12:00

12:00-12:30

Prof. Mark Stitt

Prof. Malcolm Bennett

Biosciences

MPI für Molekulare Pflanzenphysiologie, Potsdam

University of Nottingham

trennlinie.png

12:45-13:15

13:15-13:45

Prof. Edda Klipp

Prof. Hermann-Georg Holzhütter

Theoretical Sciences

Humboldt-Universität zu Berlin

Charité Berlin

trennlinie.png

15:00-15:30

15:30-16:00

Prof. Thomas Sauter

Prof. Frank Allgöwer

Computer Sciences

Université du Luxembourg

Universität Stuttgart

trennlinie.png

16:15-16:45

16:45-17:15

Dr. Jörg Lippert

Dr. Ralf Kindervater

 Industry

Bayer Technology Services GmbH

BIOPRO Baden-Württemberg GmbH

trennlinie.png

 

 Friday, 19.06.2009 · (Fee requiered for registration online)

10:00-10:45

11:00-11:45

Prof. Tewis Bouwmeester

Dr. Birgit Schörberl

Main presentations

NIBR Novartis Pharma AG

Merrimack Pharmaceuticals, Inc